Tokyo Tape
Sign in
← Medical Ikkou Group

Annual report

3353.TEDINET S100THFR
Period2023-03-01 → 2024-02-29
Filed2024-05-23
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 145
MetricValuePeriodScopeSource row
Revenue¥39.9bn2023-03-01 → 2024-02-29Cons.Net sales
Revenue¥33.9bn2022-03-01 → 2023-02-28Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28dCons.Net sales (5-year summary)
Revenue¥31.6bn2020-03-01 → 2021-02-28dCons.Net sales (5-year summary)
Revenue¥32.0bn2019-03-01 → 2020-02-29dCons.Net sales (5-year summary)
Operating income¥1.6bn2023-03-01 → 2024-02-29Cons.Operating income
Operating income¥935m2022-03-01 → 2023-02-28Cons.Operating income
Ordinary income¥1.8bn2023-03-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.2bn2022-03-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2020-03-01 → 2021-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2019-03-01 → 2020-02-29dCons.Ordinary income loss (5-year summary)
Profit before tax¥1.7bn2023-03-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥1.3bn2022-03-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥1.0bn2023-03-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥760m2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥835m2020-03-01 → 2021-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥802m2019-03-01 → 2020-02-29dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥1.1bn2023-03-01 → 2024-02-29Cons.Profit loss
Net income¥773m2022-03-01 → 2023-02-28Cons.Profit loss
Total assets¥31.7bnat 2024-02-29Cons.Assets
Total assets¥27.5bnat 2023-02-28Cons.Assets
Total assets¥29.1bnat 2022-02-28dCons.Total assets (5-year summary)
Total assets¥28.6bnat 2021-02-28dCons.Total assets (5-year summary)
Total assets¥26.2bnat 2020-02-29dCons.Total assets (5-year summary)
Total liabilities¥17.8bnat 2024-02-29Cons.Liabilities
Total liabilities¥14.9bnat 2023-02-28Cons.Liabilities
Net assets / equity¥13.8bnat 2024-02-29Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28dCons.Net assets
Net assets / equity¥10.5bnat 2021-02-28dCons.Net assets (5-year summary)
Net assets / equity¥10.2bnat 2020-02-29dCons.Net assets (5-year summary)
Cash and deposits¥7.7bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥6.4bnat 2023-02-28Cons.Cash and deposits
Cash & equivalents¥7.6bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28dCons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥5.6bnat 2020-02-29dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥4.3bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.8bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.8bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.2bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥478m2022-03-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥375m2019-03-01 → 2020-02-29dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥278m2023-03-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.4bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥591m2020-03-01 → 2021-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.1bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥276.72023-03-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥202.22022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥221.312020-03-01 → 2021-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.362019-03-01 → 2020-02-29dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥3,523.25at 2024-02-29Cons.Net assets per share (5-year summary)
Net assets per share¥3,207.14at 2023-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥3,030.61at 2022-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥2,791.36at 2021-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥2,667.87at 2020-02-29dCons.Net assets per share (5-year summary)
Equity ratio41.8%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio43.8%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio36.7%at 2021-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio38.8%at 2020-02-29dCons.Equity to asset ratio (5-year summary)
ROE8.2%2023-03-01 → 2024-02-29Cons.Rate of return on equity (5-year summary)
ROE6.5%2022-03-01 → 2023-02-28Cons.Rate of return on equity (5-year summary)
ROE7.8%2021-03-01 → 2022-02-28dCons.Rate of return on equity (5-year summary)
ROE8.1%2020-03-01 → 2021-02-28dCons.Rate of return on equity (5-year summary)
ROE8.1%2019-03-01 → 2020-02-29dCons.Rate of return on equity (5-year summary)
Employees1,431at 2024-02-29Cons.Number of employees
Employees1,297at 2023-02-28Cons.Number of employees
Employees1,325at 2022-02-28dCons.Number of employees
Employees1,304at 2021-02-28dCons.Number of employees
Employees1,187at 2020-02-29dCons.Number of employees
Revenue¥1.1bn2023-03-01 → 2024-02-29StandaloneOperating revenue1
Revenue¥1.0bn2022-03-01 → 2023-02-28StandaloneOperating revenue1
Operating income¥557m2023-03-01 → 2024-02-29StandaloneOperating income
Operating income¥491m2022-03-01 → 2023-02-28StandaloneOperating income
Ordinary income¥616m2023-03-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥592m2022-03-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥432m2021-03-01 → 2022-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥319m2020-03-01 → 2021-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥492m2019-03-01 → 2020-02-29dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥551m2023-03-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥613m2022-03-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥457m2023-03-01 → 2024-02-29StandaloneProfit loss
Net income¥526m2022-03-01 → 2023-02-28StandaloneProfit loss
Net income¥397m2021-03-01 → 2022-02-28dStandaloneNet income loss (5-year summary)
Net income¥355m2020-03-01 → 2021-02-28dStandaloneNet income loss (5-year summary)
Net income¥311m2019-03-01 → 2020-02-29dStandaloneNet income loss (5-year summary)
Total assets¥12.7bnat 2024-02-29StandaloneAssets
Total assets¥11.8bnat 2023-02-28StandaloneAssets
Total assets¥12.5bnat 2022-02-28dStandaloneTotal assets (5-year summary)
Total assets¥12.5bnat 2021-02-28dStandaloneTotal assets (5-year summary)
Total assets¥12.4bnat 2020-02-29dStandaloneTotal assets (5-year summary)
Total liabilities¥3.7bnat 2024-02-29StandaloneLiabilities
Total liabilities¥3.2bnat 2023-02-28StandaloneLiabilities
Net assets / equity¥9.0bnat 2024-02-29StandaloneNet assets
Net assets / equity¥8.6bnat 2023-02-28StandaloneNet assets
Net assets / equity¥8.3bnat 2022-02-28dStandaloneNet assets
Net assets / equity¥8.0bnat 2021-02-28dStandaloneNet assets (5-year summary)
Net assets / equity¥8.2bnat 2020-02-29dStandaloneNet assets (5-year summary)
Cash and deposits¥1.9bnat 2024-02-29StandaloneCash and deposits
Cash and deposits¥1.8bnat 2023-02-28StandaloneCash and deposits
EPS (basic)¥121.612023-03-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥140.072022-03-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥105.692021-03-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥94.222020-03-01 → 2021-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥81.562019-03-01 → 2020-02-29dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥452023-03-01 → 2024-02-29StandaloneDividend paid per share (5-year summary)
Dividend per share¥402022-03-01 → 2023-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥402021-03-01 → 2022-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥802020-03-01 → 2021-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥852019-03-01 → 2020-02-29dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,385.18at 2024-02-29StandaloneNet assets per share (5-year summary)
Net assets per share¥2,293.7at 2023-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥2,196.84at 2022-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,131.98at 2021-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,143.92at 2020-02-29dStandaloneNet assets per share (5-year summary)
Equity ratio70.8%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.2%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.3%at 2022-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2021-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio65.9%at 2020-02-29dStandaloneEquity to asset ratio (5-year summary)
ROE5.2%2023-03-01 → 2024-02-29StandaloneRate of return on equity (5-year summary)
ROE6.2%2022-03-01 → 2023-02-28StandaloneRate of return on equity (5-year summary)
ROE4.9%2021-03-01 → 2022-02-28dStandaloneRate of return on equity (5-year summary)
ROE4.4%2020-03-01 → 2021-02-28dStandaloneRate of return on equity (5-year summary)
ROE3.8%2019-03-01 → 2020-02-29dStandaloneRate of return on equity (5-year summary)
Shares issued4,070,000at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued4,070,000at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued4,070,000at 2022-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2021-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2020-02-29dStandaloneTotal number of issued shares (5-year summary)
Employees22at 2024-02-29StandaloneNumber of employees
Employees25at 2023-02-28StandaloneNumber of employees
Employees25at 2022-02-28dStandaloneNumber of employees
Employees25at 2021-02-28dStandaloneNumber of employees
Employees17at 2020-02-29dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 84
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2023-03-01 → 2024-02-29¥18m
Reconciling Itemsreconcilingdepreciation2023-03-01 → 2024-02-29¥32m
Reconciling Itemsreconcilingrevenue2023-03-01 → 2024-02-29−¥879m
Reconciling Itemsreconcilingrevenue intersegment2023-03-01 → 2024-02-29−¥879m
Reconciling Itemsreconcilingsegment assetsat 2024-02-29¥9.5bn
Reconciling Itemsreconcilingsegment profit2023-03-01 → 2024-02-29−¥329m
Dispensing Pharmacyreportable segmentcapex2023-03-01 → 2024-02-29¥265m
Dispensing Pharmacyreportable segmentdepreciation2023-03-01 → 2024-02-29¥174m
Dispensing Pharmacyreportable segmentemployeesat 2024-02-29463 pure
Dispensing Pharmacyreportable segmentrevenue2023-03-01 → 2024-02-29¥23.5bn
Dispensing Pharmacyreportable segmentrevenue external2023-03-01 → 2024-02-29¥23.5bn
Dispensing Pharmacyreportable segmentsegment assetsat 2024-02-29¥6.6bn
Dispensing Pharmacyreportable segmentsegment profit2023-03-01 → 2024-02-29¥1.4bn
Health Carereportable segmentcapex2023-03-01 → 2024-02-29¥32m
Health Carereportable segmentdepreciation2023-03-01 → 2024-02-29¥369m
Health Carereportable segmentemployeesat 2024-02-29755 pure
Health Carereportable segmentrevenue2023-03-01 → 2024-02-29¥7.7bn
Health Carereportable segmentrevenue external2023-03-01 → 2024-02-29¥7.7bn
Health Carereportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥600,000
Health Carereportable segmentsegment assetsat 2024-02-29¥9.7bn
Health Carereportable segmentsegment profit2023-03-01 → 2024-02-29¥174m
Medical Products Wholesalereportable segmentcapex2023-03-01 → 2024-02-29¥4m
Medical Products Wholesalereportable segmentdepreciation2023-03-01 → 2024-02-29¥6m
Medical Products Wholesalereportable segmentemployeesat 2024-02-29191 pure
Medical Products Wholesalereportable segmentrevenue2023-03-01 → 2024-02-29¥9.3bn
Medical Products Wholesalereportable segmentrevenue external2023-03-01 → 2024-02-29¥8.4bn
Medical Products Wholesalereportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥874m
Medical Products Wholesalereportable segmentsegment assetsat 2024-02-29¥4.2bn
Medical Products Wholesalereportable segmentsegment profit2023-03-01 → 2024-02-29¥177m
Real Estatereportable segmentcapex2023-03-01 → 2024-02-29¥2m
Real Estatereportable segmentdepreciation2023-03-01 → 2024-02-29¥32m
Real Estatereportable segmentemployeesat 2024-02-291 pure
Real Estatereportable segmentrevenue2023-03-01 → 2024-02-29¥186m
Real Estatereportable segmentrevenue external2023-03-01 → 2024-02-29¥181m
Real Estatereportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥5m
Real Estatereportable segmentsegment assetsat 2024-02-29¥1.7bn
Real Estatereportable segmentsegment profit2023-03-01 → 2024-02-29¥132m
Total Of Reportable Segments And Otherssegment totalcapex2023-03-01 → 2024-02-29¥302m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-03-01 → 2024-02-29¥581m
Total Of Reportable Segments And Otherssegment totalrevenue2023-03-01 → 2024-02-29¥40.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-03-01 → 2024-02-29¥39.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-03-01 → 2024-02-29¥879m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-02-29¥22.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-03-01 → 2024-02-29¥1.9bn
Reconciling Itemsreconcilingcapex2022-03-01 → 2023-02-28¥26m
Reconciling Itemsreconcilingdepreciation2022-03-01 → 2023-02-28¥34m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2023-02-28−¥1.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2023-02-28−¥1.0bn
Reconciling Itemsreconcilingsegment assetsat 2023-02-28¥7.3bn
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2023-02-28−¥541m
Dispensing Pharmacyreportable segmentcapex2022-03-01 → 2023-02-28¥214m
Dispensing Pharmacyreportable segmentdepreciation2022-03-01 → 2023-02-28¥160m
Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2023-02-28¥23.1bn
Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2023-02-28¥23.1bn
Dispensing Pharmacyreportable segmentsegment assetsat 2023-02-28¥7.8bn
Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2023-02-28¥1.3bn
Health Carereportable segmentcapex2022-03-01 → 2023-02-28¥67m
Health Carereportable segmentdepreciation2022-03-01 → 2023-02-28¥389m
Health Carereportable segmentrevenue2022-03-01 → 2023-02-28¥7.7bn
Health Carereportable segmentrevenue external2022-03-01 → 2023-02-28¥7.7bn
Health Carereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥600,000
Health Carereportable segmentsegment assetsat 2023-02-28¥9.5bn
Health Carereportable segmentsegment profit2022-03-01 → 2023-02-28−¥29m
Medical Products Wholesalereportable segmentdepreciation2022-03-01 → 2023-02-28¥12m
Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2023-02-28¥3.9bn
Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2023-02-28¥2.9bn
Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥998m
Medical Products Wholesalereportable segmentsegment assetsat 2023-02-28¥1.3bn
Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2023-02-28¥57m
Real Estatereportable segmentcapex2022-03-01 → 2023-02-28¥6m
Real Estatereportable segmentdepreciation2022-03-01 → 2023-02-28¥37m
Real Estatereportable segmentrevenue2022-03-01 → 2023-02-28¥189m
Real Estatereportable segmentrevenue external2022-03-01 → 2023-02-28¥187m
Real Estatereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥2m
Real Estatereportable segmentsegment assetsat 2023-02-28¥1.6bn
Real Estatereportable segmentsegment profit2022-03-01 → 2023-02-28¥125m
Total Of Reportable Segments And Otherssegment totalcapex2022-03-01 → 2023-02-28¥286m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-03-01 → 2023-02-28¥598m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2023-02-28¥34.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2023-02-28¥33.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2023-02-28¥1.0bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-02-28¥20.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2023-02-28¥1.5bn
Real Estatereportable segmentemployeesat 2024-02-291 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,510
ItemContextValueUnit
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember464
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember521
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember1688
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember111
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember24840
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember166
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember1
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember13882
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember40688
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember1200
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.0415
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.0027
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.6105
Percentage of shareholdings foreigners other than individualsCurrentYearInstant_OrdinaryShareMember0.0041
Percentage of shareholdings foreign individualsCurrentYearInstant_OrdinaryShareMember0.0000
Percentage of shareholdings individuals and othersCurrentYearInstant_OrdinaryShareMember0.3412
Number of shares heldCurrentYearInstant_No1MajorShareholdersMember1020000
Shareholding ratioCurrentYearInstant_No1MajorShareholdersMember0.2714
Number of shares heldCurrentYearInstant_No2MajorShareholdersMember360000
Shareholding ratioCurrentYearInstant_No2MajorShareholdersMember0.0957
Number of shares heldCurrentYearInstant_No3MajorShareholdersMember242400
Shareholding ratioCurrentYearInstant_No3MajorShareholdersMember0.0645
Number of shares heldCurrentYearInstant_No4MajorShareholdersMember234200
Shareholding ratioCurrentYearInstant_No4MajorShareholdersMember0.0623
Number of shares heldCurrentYearInstant_No5MajorShareholdersMember234200
Shareholding ratioCurrentYearInstant_No5MajorShareholdersMember0.0623
Number of shares heldCurrentYearInstant_No6MajorShareholdersMember203000
Shareholding ratioCurrentYearInstant_No6MajorShareholdersMember0.0540
Number of shares heldCurrentYearInstant_No7MajorShareholdersMember144946
Shareholding ratioCurrentYearInstant_No7MajorShareholdersMember0.0385
Number of shares heldCurrentYearInstant_No8MajorShareholdersMember140000
Shareholding ratioCurrentYearInstant_No8MajorShareholdersMember0.0372
Number of shares heldCurrentYearInstant_No9MajorShareholdersMember120000
Shareholding ratioCurrentYearInstant_No9MajorShareholdersMember0.0319
Number of shares heldCurrentYearInstant_No10MajorShareholdersMember100000
Shareholding ratioCurrentYearInstant_No10MajorShareholdersMember0.0266
Number of shares heldCurrentYearInstant2798746
Shareholding ratioCurrentYearInstant0.7447
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember311800
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember3757000
Number of voting rights issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember37570
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember1200
Number of shares issued shares voting rightsCurrentYearInstant4070000
Number of voting rights issued shares voting rightsCurrentYearInstant37570

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 22 of 22 passed
balance sheet identityconsolidated 2023-02-28pass
balance sheet identityconsolidated 2024-02-29pass
balance sheet identitynon_consolidated 2023-02-28pass rounding
balance sheet identitynon_consolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net assetsnon_consolidated 2022-02-28pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-03-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-03-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass